ARX:ASX
Aroa Biosurgery Ltd
A$0.50
arrow_downward
-1.96%(-0.0100) 1D
Nov 13, 4:10:11 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARX...
Open
A$0.50
High
A$0.51
Low
A$0.50
Mkt. cap
172.95M
Avg. vol.
266.66K
Volume
846.69K
P/E ratio
47.62
52-wk high
A$0.78
52-wk low
A$0.46
EPS
A$0.01
Shares outstanding
345.90M
No. of employees
261
Open
A$0.50
High
A$0.51
Low
A$0.50
Mkt. cap
172.95M
Avg. vol.
266.66K
Volume
846.69K
P/E ratio
47.62
52-wk high
A$0.78
52-wk low
A$0.46
EPS
A$0.01
Shares outstanding
345.90M
No. of employees
261
News stories
From web sources and news partners
ChartMill
·
1 hour ago
S&P 500 Gap-Down Stocks in the Nov. 13 Session
Yahoo Finance
·
58 minutes ago
Goldman Sachs sees S&P 500 surging 14% to 8,700 in 2027
MarketWatch
·
1 hour ago
Tech is dragging down the S&P 500
Profile
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
About Aroa Biosurgery Ltd